In the analysis of genomic and epigenomic aberrations, AHNAK2 was revealed to be an oncogene of thyroid cancer, and the analysis of TCGA database further showed that AHNAK2 is a biomarker for the diagnosis and prognosis of thyroid cancer [32,33] . This evidence concerns the gene AHNAK2 and thyroid gland carcinoma.